RebelBio
136
134K
75
15.11
0.44
- Stages of investment
- Areas of investment
Summary
RebelBio is the famous VC, which was founded in 2014. The main office of represented VC is situated in the London. The venture was found in Europe in United Kingdom.
The fund is generally included in 13-24 deals every year. The common things for fund are deals in the range of 100 thousands - 1 million dollars. The high activity for fund was in 2017. The typical startup value when the investment from RebelBio is 1-5 millions dollars.
Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Canada. Among the most popular portfolio startups of the fund, we may highlight Perfect Day, Chinova Bioworks, Pili. The fund has no exact preference in some founders of portfolio startups. When startup sums 1 of the founder, the probability for it to get the investment is little. We can highlight the next thriving fund investment areas, such as Artificial Intelligence, Health Care.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the RebelBio, startups are often financed by SOSV, Enterprise Ireland, The Yield Lab. The meaningful sponsors for the fund in investment in the same round are Enterprise Ireland, The Yield Lab, Dorm Room Fund. In the next rounds fund is usually obtained by SOSV, Horizons Ventures, Enterprise Ireland.
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 136
- Lead investments
- 0
- Rounds per year
- 15.11
- Follow on index
- 0.44
- Investments by industry
- Biotechnology (109)
- Health Care (26)
- Medical (17)
- Sustainability (15)
- Pharmaceutical (15) Show 74 more
- Investments by region
-
- United States (30)
- France (5)
- Ireland (37)
- United Kingdom (19)
- Mexico (3) Show 12 more
- Peak activity year
- 2017
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 5
- Avg. valuation at time of investment
- 16M
- Group Appearance index
- 0.99
- Strategy success index
- 0.30
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Chronomics | 08 Jan 2019 | Biotechnology, Medical Device, Medical, Life Science | Seed | 1M | England, London, United Kingdom |
| Microendo | 06 Mar 2019 | Biotechnology | Seed | 800K | Jalisco, Zapopan, Mexico |
| Panoply | 18 Sep 2017 | Software, Machine Learning, SaaS, Big Data, Cloud Data Services | Early Stage Venture | 6M | United States, California, San Francisco |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.